These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 33274240)
41. Trafficking of FoxP3+ regulatory T cells: myths and facts. Kim CH Arch Immunol Ther Exp (Warsz); 2007; 55(3):151-9. PubMed ID: 17557143 [TBL] [Abstract][Full Text] [Related]
42. Expression of Beclin-1, an autophagy-related protein, is associated with tumoral FOXP3 expression and Tregs in gastric adenocarcinoma: The function of Beclin-1 expression as a favorable prognostic factor in gastric adenocarcinoma. Song MJ; Park S; Won KY Pathol Res Pract; 2020 May; 216(5):152927. PubMed ID: 32204925 [TBL] [Abstract][Full Text] [Related]
43. Arginine methylation of FOXP3 is crucial for the suppressive function of regulatory T cells. Kagoya Y; Saijo H; Matsunaga Y; Guo T; Saso K; Anczurowski M; Wang CH; Sugata K; Murata K; Butler MO; Arrowsmith CH; Hirano N J Autoimmun; 2019 Feb; 97():10-21. PubMed ID: 30318155 [TBL] [Abstract][Full Text] [Related]
44. Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cells. Tao H; Mimura Y; Aoe K; Kobayashi S; Yamamoto H; Matsuda E; Okabe K; Matsumoto T; Sugi K; Ueoka H Lung Cancer; 2012 Jan; 75(1):95-101. PubMed ID: 21719142 [TBL] [Abstract][Full Text] [Related]
45. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue. Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917 [TBL] [Abstract][Full Text] [Related]
46. Regulatory T-Cell (Treg) hybridoma as a novel tool to study Foxp3 regulation and Treg fate. Sharma R; Sung SS; Ju CY; Deshmukh US; Fu SM; Ju ST J Autoimmun; 2011 Sep; 37(2):113-21. PubMed ID: 21621978 [TBL] [Abstract][Full Text] [Related]
47. FoxP3 and IDO in Canine Melanocytic Tumors. Porcellato I; Brachelente C; De Paolis L; Menchetti L; Silvestri S; Sforna M; Vichi G; Iussich S; Mechelli L Vet Pathol; 2019 Mar; 56(2):189-199. PubMed ID: 30381008 [TBL] [Abstract][Full Text] [Related]
48. Epigenetical Targeting of the FOXP3 Gene by S-Adenosylmethionine Diminishes the Suppressive Capacity of Regulatory T Cells Ex Vivo and Alters the Expression Profiles. Sahin E; Sahin M J Immunother; 2019 Jan; 42(1):11-22. PubMed ID: 30407230 [TBL] [Abstract][Full Text] [Related]
49. ICOS Nagase H; Takeoka T; Urakawa S; Morimoto-Okazawa A; Kawashima A; Iwahori K; Takiguchi S; Nishikawa H; Sato E; Sakaguchi S; Mori M; Doki Y; Wada H Int J Cancer; 2017 Feb; 140(3):686-695. PubMed ID: 27756099 [TBL] [Abstract][Full Text] [Related]
50. Exploring the role CD163-labeled TAMs and FOXP3-labeled Tregs in different types of breast cancer: Reflections and putative benefits. Shash LS; M Kamal KA; Abd Raboh NM Indian J Pathol Microbiol; 2021; 64(1):28-37. PubMed ID: 33433406 [TBL] [Abstract][Full Text] [Related]
52. Patients with oral squamous cell carcinoma are characterized by increased frequency of suppressive regulatory T cells in the blood and tumor microenvironment. Gasparoto TH; de Souza Malaspina TS; Benevides L; de Melo EJ; Costa MR; Damante JH; Ikoma MR; Garlet GP; Cavassani KA; da Silva JS; Campanelli AP Cancer Immunol Immunother; 2010 Jun; 59(6):819-28. PubMed ID: 20012605 [TBL] [Abstract][Full Text] [Related]
53. Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease. Eastaff-Leung N; Mabarrack N; Barbour A; Cummins A; Barry S J Clin Immunol; 2010 Jan; 30(1):80-9. PubMed ID: 19936899 [TBL] [Abstract][Full Text] [Related]
54. Decreased Suppression and Increased Phosphorylated STAT3 in Regulatory T Cells are Associated with Benefit from Adjuvant PD-1 Blockade in Resected Metastatic Melanoma. Woods DM; Ramakrishnan R; Laino AS; Berglund A; Walton K; Betts BC; Weber JS Clin Cancer Res; 2018 Dec; 24(24):6236-6247. PubMed ID: 30131384 [TBL] [Abstract][Full Text] [Related]
55. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART. Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058 [TBL] [Abstract][Full Text] [Related]
56. Prognostic Role of Immune Cells in Hepatitis B-associated Hepatocellular Carcinoma Following Surgical Resection Depends on Their Localization and Tumor Size. Wang Q; Luan W; Warren L; Fiel MI; Blank S; Kadri H; Mandeli J; Hiotis SP J Immunother; 2016 Jan; 39(1):36-44. PubMed ID: 26641260 [TBL] [Abstract][Full Text] [Related]
57. An increased abundance of tumor-infiltrating regulatory T cells is correlated with the progression and prognosis of pancreatic ductal adenocarcinoma. Tang Y; Xu X; Guo S; Zhang C; Tang Y; Tian Y; Ni B; Lu B; Wang H PLoS One; 2014; 9(3):e91551. PubMed ID: 24637664 [TBL] [Abstract][Full Text] [Related]
58. Expression of IL-37 contributes to the immunosuppressive property of human CD4+CD25+ regulatory T cells. Shuai X; Wei-min L; Tong YL; Dong N; Sheng ZY; Yao YM Sci Rep; 2015 Sep; 5():14478. PubMed ID: 26411375 [TBL] [Abstract][Full Text] [Related]